A Study of HSP990 Administered by Mouth in Adult Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Advanced Solid Malignancies
Interventions
DRUG

HSP990

Trial Locations (3)

31052

Novartis Investigative Site, Toulouse

M5G 2M9

Novartis Investigative Site, Toronto

08035

Novartis Investigative Site, Barcelona

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY